Malignant lymphoma (so‐called reticulum cell sarcoma) of bone
The probability of 5‐year survival for 98 patients with “primary” skeletal lymphoma was 44%. For 81 additional patients with a similar skeletal lesion producing their initial clinical problem but found to have multifocal disease, the probability of 5‐year survival was 23%. Skeletal roentgenologic su...
Gespeichert in:
| Veröffentlicht in: | Cancer 1974-10, Vol.34 (4), p.1131-1137 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1137 |
|---|---|
| container_issue | 4 |
| container_start_page | 1131 |
| container_title | Cancer |
| container_volume | 34 |
| creator | Boston, H. Chester Dahlin, David C. Ivins, John C. Cupps, Roger E. |
| description | The probability of 5‐year survival for 98 patients with “primary” skeletal lymphoma was 44%. For 81 additional patients with a similar skeletal lesion producing their initial clinical problem but found to have multifocal disease, the probability of 5‐year survival was 23%. Skeletal roentgenologic survey, sternal marrow aspiration, and probably lymphangiography should be employed in assessing such patients. Pulmonary involvement was extremely unusual. Radiation is the treatment of choice. Surgical ablation may be necessary for persistent or recurrent disease. Chemotherapy may be of value for patients with disseminated involvement. |
| doi_str_mv | 10.1002/1097-0142(197410)34:4<1131::AID-CNCR2820340424>3.0.CO;2-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_82534361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>82534361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4634-dd74332dd57aec552f47ed430d25f286bfbe1dc4805e64817db37a6ab8e64a483</originalsourceid><addsrcrecordid>eNqVkM9q20AQxpeS4DpuHyGgU0kOcmZ3R9LGKQ1G-QtpDCEB5zSstKtWZWU5WovgWx4hz9gniYRNoD0UehqG75tvZn6MTTmMOYA44nCchMBRHPDjBDkcSpzgV84ln0ym12dhepveCSVAIqDAb3IM43R2IsL5BzZ8n91hQwBQYYRy_pHtef-raxMRyQEbYAyKKxiy0-_alT8WerEK3Lpa_qwrHRz4-vfLa66dsyZo7KrMW9dWQW6dC7xu8s5zGNRFkNUL-4ntFtp5-3lbR-zh4vw-vQpvZpfX6fQmzDGWGBqToJTCmCjRNo8iUWBiDUowIiqEirMis9zkqCCyMSqemEwmOtaZ6lqNSo7Yl03usqmfWutXVJW-v0gvbN16Ut1fKGPeGR83xrypvW9sQcumrHSzJg7Uw6UeEPWAaAOXJBJSD5eog0t_wiVJQOmMBM277P3tEW1WWfOevKXZ6WajP5fOrv9n8T_3_qXIN-R2lpI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>82534361</pqid></control><display><type>article</type><title>Malignant lymphoma (so‐called reticulum cell sarcoma) of bone</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Boston, H. Chester ; Dahlin, David C. ; Ivins, John C. ; Cupps, Roger E.</creator><creatorcontrib>Boston, H. Chester ; Dahlin, David C. ; Ivins, John C. ; Cupps, Roger E.</creatorcontrib><description>The probability of 5‐year survival for 98 patients with “primary” skeletal lymphoma was 44%. For 81 additional patients with a similar skeletal lesion producing their initial clinical problem but found to have multifocal disease, the probability of 5‐year survival was 23%. Skeletal roentgenologic survey, sternal marrow aspiration, and probably lymphangiography should be employed in assessing such patients. Pulmonary involvement was extremely unusual. Radiation is the treatment of choice. Surgical ablation may be necessary for persistent or recurrent disease. Chemotherapy may be of value for patients with disseminated involvement.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(197410)34:4<1131::AID-CNCR2820340424>3.0.CO;2-X</identifier><identifier>PMID: 4608180</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; Aged ; Amputation ; Bone Neoplasms - diagnosis ; Bone Neoplasms - diagnostic imaging ; Bone Neoplasms - pathology ; Bone Neoplasms - radiotherapy ; Bone Neoplasms - surgery ; Child ; Female ; Hodgkin Disease - diagnosis ; Hodgkin Disease - diagnostic imaging ; Hodgkin Disease - pathology ; Hodgkin Disease - radiotherapy ; Hodgkin Disease - surgery ; Humans ; Lung Neoplasms ; Lymphography ; Lymphoma, Non-Hodgkin - diagnosis ; Lymphoma, Non-Hodgkin - diagnostic imaging ; Lymphoma, Non-Hodgkin - pathology ; Lymphoma, Non-Hodgkin - radiotherapy ; Lymphoma, Non-Hodgkin - surgery ; Male ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Terminology as Topic</subject><ispartof>Cancer, 1974-10, Vol.34 (4), p.1131-1137</ispartof><rights>Copyright © 1974 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4634-dd74332dd57aec552f47ed430d25f286bfbe1dc4805e64817db37a6ab8e64a483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4608180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boston, H. Chester</creatorcontrib><creatorcontrib>Dahlin, David C.</creatorcontrib><creatorcontrib>Ivins, John C.</creatorcontrib><creatorcontrib>Cupps, Roger E.</creatorcontrib><title>Malignant lymphoma (so‐called reticulum cell sarcoma) of bone</title><title>Cancer</title><addtitle>Cancer</addtitle><description>The probability of 5‐year survival for 98 patients with “primary” skeletal lymphoma was 44%. For 81 additional patients with a similar skeletal lesion producing their initial clinical problem but found to have multifocal disease, the probability of 5‐year survival was 23%. Skeletal roentgenologic survey, sternal marrow aspiration, and probably lymphangiography should be employed in assessing such patients. Pulmonary involvement was extremely unusual. Radiation is the treatment of choice. Surgical ablation may be necessary for persistent or recurrent disease. Chemotherapy may be of value for patients with disseminated involvement.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Amputation</subject><subject>Bone Neoplasms - diagnosis</subject><subject>Bone Neoplasms - diagnostic imaging</subject><subject>Bone Neoplasms - pathology</subject><subject>Bone Neoplasms - radiotherapy</subject><subject>Bone Neoplasms - surgery</subject><subject>Child</subject><subject>Female</subject><subject>Hodgkin Disease - diagnosis</subject><subject>Hodgkin Disease - diagnostic imaging</subject><subject>Hodgkin Disease - pathology</subject><subject>Hodgkin Disease - radiotherapy</subject><subject>Hodgkin Disease - surgery</subject><subject>Humans</subject><subject>Lung Neoplasms</subject><subject>Lymphography</subject><subject>Lymphoma, Non-Hodgkin - diagnosis</subject><subject>Lymphoma, Non-Hodgkin - diagnostic imaging</subject><subject>Lymphoma, Non-Hodgkin - pathology</subject><subject>Lymphoma, Non-Hodgkin - radiotherapy</subject><subject>Lymphoma, Non-Hodgkin - surgery</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Prognosis</subject><subject>Terminology as Topic</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1974</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM9q20AQxpeS4DpuHyGgU0kOcmZ3R9LGKQ1G-QtpDCEB5zSstKtWZWU5WovgWx4hz9gniYRNoD0UehqG75tvZn6MTTmMOYA44nCchMBRHPDjBDkcSpzgV84ln0ym12dhepveCSVAIqDAb3IM43R2IsL5BzZ8n91hQwBQYYRy_pHtef-raxMRyQEbYAyKKxiy0-_alT8WerEK3Lpa_qwrHRz4-vfLa66dsyZo7KrMW9dWQW6dC7xu8s5zGNRFkNUL-4ntFtp5-3lbR-zh4vw-vQpvZpfX6fQmzDGWGBqToJTCmCjRNo8iUWBiDUowIiqEirMis9zkqCCyMSqemEwmOtaZ6lqNSo7Yl03usqmfWutXVJW-v0gvbN16Ut1fKGPeGR83xrypvW9sQcumrHSzJg7Uw6UeEPWAaAOXJBJSD5eog0t_wiVJQOmMBM277P3tEW1WWfOevKXZ6WajP5fOrv9n8T_3_qXIN-R2lpI</recordid><startdate>197410</startdate><enddate>197410</enddate><creator>Boston, H. Chester</creator><creator>Dahlin, David C.</creator><creator>Ivins, John C.</creator><creator>Cupps, Roger E.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197410</creationdate><title>Malignant lymphoma (so‐called reticulum cell sarcoma) of bone</title><author>Boston, H. Chester ; Dahlin, David C. ; Ivins, John C. ; Cupps, Roger E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4634-dd74332dd57aec552f47ed430d25f286bfbe1dc4805e64817db37a6ab8e64a483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1974</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Amputation</topic><topic>Bone Neoplasms - diagnosis</topic><topic>Bone Neoplasms - diagnostic imaging</topic><topic>Bone Neoplasms - pathology</topic><topic>Bone Neoplasms - radiotherapy</topic><topic>Bone Neoplasms - surgery</topic><topic>Child</topic><topic>Female</topic><topic>Hodgkin Disease - diagnosis</topic><topic>Hodgkin Disease - diagnostic imaging</topic><topic>Hodgkin Disease - pathology</topic><topic>Hodgkin Disease - radiotherapy</topic><topic>Hodgkin Disease - surgery</topic><topic>Humans</topic><topic>Lung Neoplasms</topic><topic>Lymphography</topic><topic>Lymphoma, Non-Hodgkin - diagnosis</topic><topic>Lymphoma, Non-Hodgkin - diagnostic imaging</topic><topic>Lymphoma, Non-Hodgkin - pathology</topic><topic>Lymphoma, Non-Hodgkin - radiotherapy</topic><topic>Lymphoma, Non-Hodgkin - surgery</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Prognosis</topic><topic>Terminology as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boston, H. Chester</creatorcontrib><creatorcontrib>Dahlin, David C.</creatorcontrib><creatorcontrib>Ivins, John C.</creatorcontrib><creatorcontrib>Cupps, Roger E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boston, H. Chester</au><au>Dahlin, David C.</au><au>Ivins, John C.</au><au>Cupps, Roger E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Malignant lymphoma (so‐called reticulum cell sarcoma) of bone</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1974-10</date><risdate>1974</risdate><volume>34</volume><issue>4</issue><spage>1131</spage><epage>1137</epage><pages>1131-1137</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>The probability of 5‐year survival for 98 patients with “primary” skeletal lymphoma was 44%. For 81 additional patients with a similar skeletal lesion producing their initial clinical problem but found to have multifocal disease, the probability of 5‐year survival was 23%. Skeletal roentgenologic survey, sternal marrow aspiration, and probably lymphangiography should be employed in assessing such patients. Pulmonary involvement was extremely unusual. Radiation is the treatment of choice. Surgical ablation may be necessary for persistent or recurrent disease. Chemotherapy may be of value for patients with disseminated involvement.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>4608180</pmid><doi>10.1002/1097-0142(197410)34:4<1131::AID-CNCR2820340424>3.0.CO;2-X</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 1974-10, Vol.34 (4), p.1131-1137 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_82534361 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adolescent Adult Aged Amputation Bone Neoplasms - diagnosis Bone Neoplasms - diagnostic imaging Bone Neoplasms - pathology Bone Neoplasms - radiotherapy Bone Neoplasms - surgery Child Female Hodgkin Disease - diagnosis Hodgkin Disease - diagnostic imaging Hodgkin Disease - pathology Hodgkin Disease - radiotherapy Hodgkin Disease - surgery Humans Lung Neoplasms Lymphography Lymphoma, Non-Hodgkin - diagnosis Lymphoma, Non-Hodgkin - diagnostic imaging Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - radiotherapy Lymphoma, Non-Hodgkin - surgery Male Middle Aged Neoplasm Metastasis Prognosis Terminology as Topic |
| title | Malignant lymphoma (so‐called reticulum cell sarcoma) of bone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T06%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Malignant%20lymphoma%20(so%E2%80%90called%20reticulum%20cell%20sarcoma)%20of%20bone&rft.jtitle=Cancer&rft.au=Boston,%20H.%20Chester&rft.date=1974-10&rft.volume=34&rft.issue=4&rft.spage=1131&rft.epage=1137&rft.pages=1131-1137&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(197410)34:4%3C1131::AID-CNCR2820340424%3E3.0.CO;2-X&rft_dat=%3Cproquest_cross%3E82534361%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=82534361&rft_id=info:pmid/4608180&rfr_iscdi=true |